Having trouble viewing this email? See the online version Monday, September 30, 2024 Monday, September 30, 2024 Insurance J&J drops 340B rebate model following HRSA pressure The agency said Johnson & Johnson faced sanctions because the plan violated 340B drug discount program rules and had not received federal approval. Read More > RELATED ARTICLES HRSA orders J&J to drop controversial 340B rebate model Hospitals seek fines against Johnson & Johnson in 340B battle States build momentum to protect 340B drug discounts - for now